- Global Pharma News & Resources

Almirall to participate in J.P. Morgan Healthcare Conference in San Francisco

Almirall, S.A. (ALM) will present a corporate update at the J.P Morgan Healthcare Conference, which celebrates its 38th edition. Almirall’s session will take place on Wednesday, January 15, at 8:30 a.m. Pacific Time / 17:30 p.m. CET at the Westin St. Francis Hotel in San Francisco. The presentation will be followed by a question and answer session, which is scheduled to begin at 9:00 am Pacific Time. A life webcast will be accessible on Almirall’s website. 

The J.P. Morgan Health Conference is an annual event that is taking place from January 13th to 16th in the city of San Francisco (US). 

About Almirall

Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying science to provide medical solutions to patients and future generations. Our efforts are focused on fighting skin health diseases and helping people feel better. We support healthcare professionals in their continuous improvements, providing our innovative solutions where they are needed.

The company was founded almost 75 years ago and has its headquarters in Barcelona. It is listed on the Spanish Stock Exchange (ticker: ALM). Almirall has become a key source of value creation for society thanks to its commitment to its principal shareholders and its decision to help others by understanding their challenges and using science to provide solutions for real life. Total revenues in 2018 were 811 million euros. Almirall has more than 1,800 employees dedicated to research.

For more information, please visit   

Editor Details

  • Company:
    • Almirall
  • Name:
    • Almirall
Last Updated: 15-Jan-2020